The Effect of Active Vitamin D on Diabetic Nephropathy A Meta-Analysis of Randomized Controlled Trials

Xin Mou, D. Zhou, Danyang Zhou
{"title":"The Effect of Active Vitamin D on Diabetic Nephropathy A Meta-Analysis of Randomized Controlled Trials","authors":"Xin Mou, D. Zhou, Danyang Zhou","doi":"10.31031/rism.2019.04.00596","DOIUrl":null,"url":null,"abstract":"Objective: The system evaluation of clinical curative effect of different concentration active vitamin D for diabetic nephropathy. Methods: We searched the Chinese VIP, Wan Fang Data, China National Knowledge Infrastructure, PubMed, Embase, and Google Scholar databases for relevant studies and extracted all eligible data. RevMan5.3 software was used for statistical analysis. Result: 20 randomized controlled trials (n=1450) met our criteria and were used for data extraction. The treatment groups have 856 cases and the control groups have 594 cases. The results of statistical analysis show that compared with the group of using ACEI/ARB simply, the combination of ACEI/ARB and different doses active vitamin d (0.25ug/d, 0.50ug/d, 0.25-0.5ug/d)can significantly reduce the 24-hour urinary protein (0.46%, P<0.00001) and (0.22%, P < 0.00001), and can decrease the hypersensitive C-reactive protein (0.63%, P=0.001) and (0.6%, P < 0.00001).However, there was no obvious difference in glycosylated hemoglobin and glomerular filtration rate, lower serum creatinine, increase calcium ion concentration. Conclusion: Meta-analysis showed that compared with the group of using ACEI/ARB simply, the impact of active vitamin D on diabetic nephropathy obviously, Especially 24-hour urine protein and hypersensitivity C-reactive protein. more randomized controlled trials are needed to be confirmed.","PeriodicalId":104100,"journal":{"name":"Research & Investigations in Sports Medicine","volume":"59 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research & Investigations in Sports Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31031/rism.2019.04.00596","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: The system evaluation of clinical curative effect of different concentration active vitamin D for diabetic nephropathy. Methods: We searched the Chinese VIP, Wan Fang Data, China National Knowledge Infrastructure, PubMed, Embase, and Google Scholar databases for relevant studies and extracted all eligible data. RevMan5.3 software was used for statistical analysis. Result: 20 randomized controlled trials (n=1450) met our criteria and were used for data extraction. The treatment groups have 856 cases and the control groups have 594 cases. The results of statistical analysis show that compared with the group of using ACEI/ARB simply, the combination of ACEI/ARB and different doses active vitamin d (0.25ug/d, 0.50ug/d, 0.25-0.5ug/d)can significantly reduce the 24-hour urinary protein (0.46%, P<0.00001) and (0.22%, P < 0.00001), and can decrease the hypersensitive C-reactive protein (0.63%, P=0.001) and (0.6%, P < 0.00001).However, there was no obvious difference in glycosylated hemoglobin and glomerular filtration rate, lower serum creatinine, increase calcium ion concentration. Conclusion: Meta-analysis showed that compared with the group of using ACEI/ARB simply, the impact of active vitamin D on diabetic nephropathy obviously, Especially 24-hour urine protein and hypersensitivity C-reactive protein. more randomized controlled trials are needed to be confirmed.
活性维生素D对糖尿病肾病的影响:随机对照试验的荟萃分析
目的:系统评价不同浓度活性维生素D治疗糖尿病肾病的临床疗效。方法:检索中国VIP、万方数据、中国国家知识基础设施、PubMed、Embase、Google Scholar等数据库进行相关研究,提取所有符合条件的数据。采用RevMan5.3软件进行统计分析。结果:20个随机对照试验(n=1450)符合我们的标准,用于数据提取。治疗组856例,对照组594例。统计分析结果显示,与单纯使用ACEI/ARB组相比,ACEI/ARB联合不同剂量的活性维生素d (0.25ug/d、0.50ug/d、0.25 ~ 0.5ug/d)可显著降低24小时尿蛋白(0.46%,P<0.00001)和(0.22%,P<0.00001),可降低超敏感c反应蛋白(0.63%,P=0.001)和(0.6%,P<0.00001)。而糖化血红蛋白和肾小球滤过率无明显差异,血清肌酐降低,钙离子浓度升高。结论:荟萃分析显示,与单纯使用ACEI/ARB组相比,活性维生素D对糖尿病肾病的影响明显,尤其是24小时尿蛋白和超敏c反应蛋白。需要更多的随机对照试验来证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书